Ken Research Logo

Saudi Arabia Point of Care Glucose Testing Market

Saudi Arabia POC Glucose Testing Market, valued at USD 45M, grows with rising diabetes cases, health awareness, and innovations in SMBG meters and CGM systems for hospitals and home care.

Region:Middle East

Author(s):Shubham

Product Code:KRAD5321

Pages:95

Published On:December 2025

About the Report

Base Year 2024

Saudi Arabia Point of Care Glucose Testing Market Overview

  • The Saudi Arabia Point of Care Glucose Testing Market is valued at USD 45 million, based on a five-year historical analysis. This growth is primarily driven by the increasing prevalence of diabetes reaching 23.1% among adults, rising health awareness, and the demand for rapid diagnostic solutions. The market is also supported by advancements in technology, which have led to the development of more efficient and user-friendly glucose testing devices.
  • Key cities such as Riyadh, Jeddah, and Dammam dominate the market due to their advanced healthcare infrastructure and high population density. These urban centers are home to numerous hospitals and clinics that utilize point-of-care testing, thereby driving demand for glucose testing devices. Additionally, the concentration of healthcare professionals and patients in these areas facilitates the adoption of innovative medical technologies.
  • The Health Sector Transformation Program Rules, 2022 issued by the Ministry of Health require primary healthcare centers to equip facilities with point-of-care diagnostic devices including glucose testing tools for populations exceeding 30,000, mandating compliance through annual audits and ISO 15197 accuracy standards for glucose meters to ensure reliable diabetes screening and management.
Saudi Arabia Point of Care Glucose Testing Market Size

Saudi Arabia Point of Care Glucose Testing Market Segmentation

By Product Type:

Saudi Arabia Point of Care Glucose Testing Market segmentation by Product Type.

The product type segmentation includes Self-Monitoring Blood Glucose (SMBG) Meters, Test Strips, Lancets and Lancing Devices, Continuous Glucose Monitoring (CGM) Systems and Sensors, Networked/Connectivity-Enabled Glucometers, and Others. Among these, Self-Monitoring Blood Glucose (SMBG) Meters dominate the market due to their widespread use among diabetic patients for daily monitoring. The convenience and accuracy of SMBG meters have made them a preferred choice for both healthcare providers and patients. Test strips also hold a significant share, as they are essential for the operation of SMBG meters. The increasing trend of home healthcare and self-monitoring further supports the growth of these segments.

By Setting / End-User:

Saudi Arabia Point of Care Glucose Testing Market segmentation by Setting / End-User.

This segmentation includes Hospitals, Clinics and Physician Offices, Home Care & Self-Monitoring, Diagnostic Laboratories & Emergency Departments, and Others. Hospitals are the leading end-users of point-of-care glucose testing devices due to their need for immediate patient care and monitoring. The increasing number of diabetes patients requiring hospitalization has led to a higher demand for glucose testing in these settings. Home care and self-monitoring are also gaining traction as more patients prefer to manage their diabetes independently, further driving the market.

Saudi Arabia Point of Care Glucose Testing Market Competitive Landscape

The Saudi Arabia Point of Care Glucose Testing Market is characterized by a dynamic mix of regional and international players. Leading participants such as Abbott Diabetes Care (Abbott Laboratories), Roche Diabetes Care (F. Hoffmann?La Roche AG), Ascensia Diabetes Care, LifeScan, Inc., ARKRAY, Inc., ACON Laboratories, Inc., Nova Biomedical Corporation, Dexcom, Inc., Medtronic plc, B. Braun Melsungen AG, Siemens Healthineers AG, Ypsomed AG, Terumo Corporation, Nipro Corporation, i-SENS, Inc. contribute to innovation, geographic expansion, and service delivery in this space.

Abbott Diabetes Care

1888

Chicago, USA

Roche Diabetes Care

1896

Basel, Switzerland

Ascensia Diabetes Care

2016

Basel, Switzerland

LifeScan, Inc.

1981

Malvern, USA

ARKRAY, Inc.

1960

Kyoto, Japan

Company

Establishment Year

Headquarters

Global Group Size (Large, Medium, or Small as per industry convention)

Saudi Arabia Point-of-Care Glucose Testing Revenue

3–5 Year Revenue Growth Rate in Saudi Arabia

Installed Base of Devices in Saudi Arabia (Units)

Market Share in Saudi Arabia POC Glucose Testing (%)

Product Portfolio Breadth (Meters, Strips, CGM, Connectivity)

Saudi Arabia Point of Care Glucose Testing Market Industry Analysis

Growth Drivers

  • Increasing Prevalence of Diabetes:The prevalence of diabetes in Saudi Arabia has reached alarming levels, with approximately 4.5 million adults diagnosed as of recent data. This figure is projected to rise, driven by lifestyle changes and urbanization. The World Health Organization estimates that by the next few years, the number of diabetes cases could increase by 10%, necessitating more efficient glucose testing solutions. This growing patient population is a significant driver for the demand for point-of-care glucose testing devices.
  • Rising Awareness of Early Diagnosis:Public health campaigns in Saudi Arabia have significantly increased awareness regarding the importance of early diabetes diagnosis. The Ministry of Health reported a 35% increase in health screenings over the past two years, emphasizing the need for accessible testing solutions. This heightened awareness is driving demand for point-of-care glucose testing, as patients seek immediate results and healthcare providers aim to facilitate timely interventions.
  • Technological Advancements in Testing Devices:The point-of-care glucose testing market is witnessing rapid technological advancements, with innovations such as non-invasive testing devices and smart glucose meters. In recent data, the introduction of devices that integrate with mobile applications has gained traction, enhancing user experience. The Saudi Arabian market is expected to benefit from these advancements, as they improve accuracy and convenience, thus driving adoption rates among both healthcare providers and patients.

Market Challenges

  • High Cost of Advanced Testing Devices:The high cost associated with advanced point-of-care glucose testing devices poses a significant barrier to market growth. Many of these devices can exceed SAR 2,500, making them less accessible for healthcare facilities, particularly in rural areas. This financial constraint limits the widespread adoption of innovative testing solutions, hindering efforts to improve diabetes management across the country.
  • Limited Access in Rural Areas:Access to point-of-care glucose testing remains a challenge in rural regions of Saudi Arabia, where healthcare infrastructure is often underdeveloped. According to the Saudi Health Council, approximately 35% of the population in these areas lacks access to essential health services. This disparity in healthcare access limits the effectiveness of diabetes management initiatives and reduces the overall market potential for glucose testing devices in these regions.

Saudi Arabia Point of Care Glucose Testing Market Future Outlook

The future of the point-of-care glucose testing market in Saudi Arabia appears promising, driven by ongoing technological innovations and increasing healthcare investments. The government is expected to enhance its focus on preventive healthcare, which will likely lead to more comprehensive screening programs. Additionally, the integration of telehealth services is anticipated to facilitate remote monitoring, further expanding the market. As healthcare providers adapt to these trends, the demand for efficient and user-friendly testing solutions will continue to grow.

Market Opportunities

  • Expansion of Telehealth Services:The rise of telehealth services in Saudi Arabia presents a significant opportunity for point-of-care glucose testing. With an estimated 60% increase in telehealth consultations in recent data, integrating glucose testing into these services can enhance patient management and accessibility, particularly for those in remote areas.
  • Development of User-Friendly Devices:There is a growing demand for user-friendly glucose testing devices that cater to a broader demographic, including the elderly and those with limited technical skills. In future, the market for simplified testing solutions is expected to expand, driven by innovations that prioritize ease of use and accessibility, thereby increasing patient compliance and satisfaction.

Scope of the Report

SegmentSub-Segments
By Product Type

Self-Monitoring Blood Glucose (SMBG) Meters

Test Strips

Lancets and Lancing Devices

Continuous Glucose Monitoring (CGM) Systems and Sensors

Networked/Connectivity-Enabled Glucometers

Others

By Setting / End-User

Hospitals

Clinics and Physician Offices

Home Care & Self-Monitoring

Diagnostic Laboratories & Emergency Departments

Others

By Distribution Channel

Hospital & Institutional Procurement

Retail Pharmacies & Drug Stores

Online Pharmacies & E?Commerce Platforms

Direct Tenders and Distributors

Others

By Region

Central Region

Eastern Region

Western Region

Southern Region

By Technology

Enzymatic Electrochemical Technology

Non?Enzymatic / Next?Generation Sensing Technology

Others

By Application

Diabetes Self?Management

In?Hospital Bedside Glucose Monitoring

Critical Care & Emergency Care

Clinical Research and Trials

Others

By Payer & Policy Support

Government Reimbursement & Public Insurance Coverage

Private Insurance Coverage

Subsidies & Price Support for Point?of?Care Devices

Incentives for Local Manufacturing & Localization

Others

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Saudi Food and Drug Authority, Ministry of Health)

Manufacturers and Producers

Distributors and Retailers

Healthcare Providers and Hospitals

Pharmaceutical Companies

Health Insurance Companies

Medical Device Regulatory Consultants

Players Mentioned in the Report:

Abbott Diabetes Care (Abbott Laboratories)

Roche Diabetes Care (F. HoffmannLa Roche AG)

Ascensia Diabetes Care

LifeScan, Inc.

ARKRAY, Inc.

ACON Laboratories, Inc.

Nova Biomedical Corporation

Dexcom, Inc.

Medtronic plc

B. Braun Melsungen AG

Siemens Healthineers AG

Ypsomed AG

Terumo Corporation

Nipro Corporation

i-SENS, Inc.

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Saudi Arabia Point of Care Glucose Testing Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Saudi Arabia Point of Care Glucose Testing Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Saudi Arabia Point of Care Glucose Testing Market Analysis

3.1 Growth Drivers

3.1.1 Increasing prevalence of diabetes
3.1.2 Rising awareness of early diagnosis
3.1.3 Technological advancements in testing devices
3.1.4 Government initiatives promoting health screenings

3.2 Market Challenges

3.2.1 High cost of advanced testing devices
3.2.2 Limited access in rural areas
3.2.3 Regulatory hurdles for new products
3.2.4 Competition from traditional laboratory testing

3.3 Market Opportunities

3.3.1 Expansion of telehealth services
3.3.2 Development of user-friendly devices
3.3.3 Partnerships with healthcare providers
3.3.4 Increasing demand for home testing solutions

3.4 Market Trends

3.4.1 Shift towards personalized medicine
3.4.2 Integration of mobile health applications
3.4.3 Growth in point-of-care testing settings
3.4.4 Focus on data analytics for patient management

3.5 Government Regulation

3.5.1 Stricter quality control measures
3.5.2 Approval processes for new devices
3.5.3 Guidelines for point-of-care testing
3.5.4 Incentives for local manufacturing

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Saudi Arabia Point of Care Glucose Testing Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Saudi Arabia Point of Care Glucose Testing Market Segmentation

8.1 By Product Type

8.1.1 Self-Monitoring Blood Glucose (SMBG) Meters
8.1.2 Test Strips
8.1.3 Lancets and Lancing Devices
8.1.4 Continuous Glucose Monitoring (CGM) Systems and Sensors
8.1.5 Networked/Connectivity-Enabled Glucometers
8.1.6 Others

8.2 By Setting / End-User

8.2.1 Hospitals
8.2.2 Clinics and Physician Offices
8.2.3 Home Care & Self-Monitoring
8.2.4 Diagnostic Laboratories & Emergency Departments
8.2.5 Others

8.3 By Distribution Channel

8.3.1 Hospital & Institutional Procurement
8.3.2 Retail Pharmacies & Drug Stores
8.3.3 Online Pharmacies & E?Commerce Platforms
8.3.4 Direct Tenders and Distributors
8.3.5 Others

8.4 By Region

8.4.1 Central Region
8.4.2 Eastern Region
8.4.3 Western Region
8.4.4 Southern Region

8.5 By Technology

8.5.1 Enzymatic Electrochemical Technology
8.5.2 Non?Enzymatic / Next?Generation Sensing Technology
8.5.3 Others

8.6 By Application

8.6.1 Diabetes Self?Management
8.6.2 In?Hospital Bedside Glucose Monitoring
8.6.3 Critical Care & Emergency Care
8.6.4 Clinical Research and Trials
8.6.5 Others

8.7 By Payer & Policy Support

8.7.1 Government Reimbursement & Public Insurance Coverage
8.7.2 Private Insurance Coverage
8.7.3 Subsidies & Price Support for Point?of?Care Devices
8.7.4 Incentives for Local Manufacturing & Localization
8.7.5 Others

9. Saudi Arabia Point of Care Glucose Testing Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Global Group Size (Large, Medium, or Small as per industry convention)
9.2.3 Saudi Arabia Point-of-Care Glucose Testing Revenue
9.2.4 3–5 Year Revenue Growth Rate in Saudi Arabia
9.2.5 Installed Base of Devices in Saudi Arabia (Units)
9.2.6 Market Share in Saudi Arabia POC Glucose Testing (%)
9.2.7 Product Portfolio Breadth (Meters, Strips, CGM, Connectivity)
9.2.8 Regulatory Approvals & SFDA Registrations Count
9.2.9 Distribution Network Strength (Number of Local Distributors / Coverage of Key Regions)
9.2.10 Average Selling Price Positioning (Premium, Mid, Economy)
9.2.11 R&D / Innovation Intensity (POC Glucose?Related Patents / New Launches)
9.2.12 Local Partnerships & Tender Wins with Government/Institutional Buyers
9.2.13 After?Sales & Technical Support Coverage in Saudi Arabia

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 Abbott Diabetes Care (Abbott Laboratories)
9.5.2 Roche Diabetes Care (F. Hoffmann?La Roche AG)
9.5.3 Ascensia Diabetes Care
9.5.4 LifeScan, Inc.
9.5.5 ARKRAY, Inc.
9.5.6 ACON Laboratories, Inc.
9.5.7 Nova Biomedical Corporation
9.5.8 Dexcom, Inc.
9.5.9 Medtronic plc
9.5.10 B. Braun Melsungen AG
9.5.11 Siemens Healthineers AG
9.5.12 Ypsomed AG
9.5.13 Terumo Corporation
9.5.14 Nipro Corporation
9.5.15 i-SENS, Inc.

10. Saudi Arabia Point of Care Glucose Testing Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Budget Allocation for Health Initiatives
10.1.2 Preference for Local Suppliers
10.1.3 Evaluation Criteria for Procurement
10.1.4 Frequency of Procurement Cycles

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment in Health Technology
10.2.2 Budget for Employee Health Programs
10.2.3 Partnerships with Health Tech Firms
10.2.4 Focus on Preventive Health Measures

10.3 Pain Point Analysis by End-User Category

10.3.1 Challenges in Device Accessibility
10.3.2 Need for Training and Support
10.3.3 Integration with Existing Systems
10.3.4 Cost Concerns for End-Users

10.4 User Readiness for Adoption

10.4.1 Awareness of Point-of-Care Testing
10.4.2 Training Needs for Healthcare Providers
10.4.3 Acceptance of New Technologies
10.4.4 Feedback Mechanisms for Improvement

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Measurement of Cost Savings
10.5.2 User Experience Feedback
10.5.3 Opportunities for Upselling
10.5.4 Long-term Health Outcomes Assessment

11. Saudi Arabia Point of Care Glucose Testing Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Business Model Framework


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban Retail Strategies

3.2 Rural NGO Tie-ups


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands Analysis


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-sales Service


7. Value Proposition

7.1 Sustainability Initiatives

7.2 Integrated Supply Chains


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding Efforts

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix Considerations
9.1.2 Pricing Band Strategy
9.1.3 Packaging Innovations

9.2 Export Entry Strategy

9.2.1 Target Countries Identification
9.2.2 Compliance Roadmap Development

10. Entry Mode Assessment

10.1 Joint Ventures

10.2 Greenfield Investments

10.3 Mergers & Acquisitions

10.4 Distributor Model Evaluation


11. Capital and Timeline Estimation

11.1 Capital Requirements Analysis

11.2 Timelines for Market Entry


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-term Sustainability Assessment


14. Potential Partner List

14.1 Distributors

14.2 Joint Ventures

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Milestone Planning
15.2.2 Activity Tracking

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of market reports from health organizations and government health ministries in Saudi Arabia
  • Review of published articles and journals focusing on diabetes management and glucose testing technologies
  • Examination of trade publications and industry white papers related to point of care testing (POCT) in the healthcare sector

Primary Research

  • Interviews with healthcare professionals, including endocrinologists and diabetes educators
  • Surveys conducted with hospital administrators and procurement managers regarding glucose testing devices
  • Focus group discussions with patients using point of care glucose testing devices to gather user experience insights

Validation & Triangulation

  • Cross-validation of findings through multiple data sources, including healthcare expenditure reports and market trends
  • Triangulation of qualitative insights from interviews with quantitative data from surveys
  • Sanity checks performed through expert panel reviews comprising industry veterans and market analysts

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of the total addressable market based on national healthcare spending and diabetes prevalence rates
  • Segmentation of the market by end-user categories, including hospitals, clinics, and home care settings
  • Incorporation of government health initiatives aimed at improving diabetes management and screening

Bottom-up Modeling

  • Collection of sales data from leading manufacturers of point of care glucose testing devices
  • Estimation of market share based on unit sales and pricing strategies of key players
  • Volume and revenue projections based on historical sales trends and growth rates in the healthcare sector

Forecasting & Scenario Analysis

  • Multi-factor regression analysis incorporating factors such as population growth, diabetes incidence, and healthcare access
  • Scenario modeling based on potential changes in healthcare policies and technological advancements in glucose testing
  • Development of baseline, optimistic, and pessimistic forecasts through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Hospital Administration100Hospital Administrators, Procurement Managers
Diabetes Care Clinics80Clinic Managers, Diabetes Educators
Home Care Providers70Home Health Care Coordinators, Patient Care Managers
Patient User Experience90Diabetes Patients, Caregivers
Healthcare Technology Experts60Medical Device Engineers, Health IT Specialists

Frequently Asked Questions

What is the current value of the Saudi Arabia Point of Care Glucose Testing Market?

The Saudi Arabia Point of Care Glucose Testing Market is valued at approximately USD 45 million, reflecting a significant growth driven by the rising prevalence of diabetes and increasing demand for rapid diagnostic solutions.

What factors are driving the growth of the Point of Care Glucose Testing Market in Saudi Arabia?

Which cities in Saudi Arabia are leading in the Point of Care Glucose Testing Market?

What are the regulatory requirements for glucose testing devices in Saudi Arabia?

Other Regional/Country Reports

Indonesia Point of Care Glucose Testing Market

Malaysia Point of Care Glucose Testing Market

KSA Point of Care Glucose Testing Market

APAC Point of Care Glucose Testing Market

SEA Point of Care Glucose Testing Market

Vietnam Point of Care Glucose Testing Market

Other Adjacent Reports

UAE Continuous Glucose Monitoring Market

South Africa Self-Monitoring Blood Glucose Market

Kuwait Insulin Delivery Systems Market

Brazil Diabetes Management Software Market

Vietnam Telemedicine Services Market

Japan Home Healthcare Devices Market

Kuwait Wearable Health Technology Market

Saudi Arabia In-Vitro Diagnostics Market Outlook to 2030GCC Pacific Clinical Laboratory Services Market

Mexico Diabetes Therapeutics Market

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022